Advanced Oncotherapy (AVO) – Technological milestones update – CCL units

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the completion of a further technological milestone in the manufacture of its first LIGHT system. Delivery of CCLs The Company confirms that the final Coupled Cavity Linac (CCL) module, to be used to generate a beam capable of treating superficial […]

AVO – More LIGHT at the end of the tunnel – Wall Street Wires

by Spekulator at Wall Street Wires Quick reminder. I am an active investor into smaller companies where I see (a) genuine value (b) good management (c) an unusual or groundbreaking product. Mostly a,b and c have to be present and correct, but I will make exceptions. I am invested into companies listed on Nasdaq, London […]

Advanced Oncotherapy (AVO) – Result of AGM

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed. For further information, please contact: Advanced Oncotherapy Plc www.avoplc.com Dr. Michael Sinclair, Executive Chairman Tel: +44 20 3617 8728 Nicolas Serandour, CEO Stockdale Securities (Nomad & Joint Broker) Antonio […]

Advanced Oncotherapy (AVO) – Financing facility provided by significant shareholders

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a consortium formed by AB Segulah and other investors has made available a £3.9m loan to the Company.  The loan will have a two year maturity and a 12% per annum rolled up interest rate.  The Segulah group includes AB Segulah, a […]

Advanced Oncotherapy (AVO) – Video and update on progress at Harley Street

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the release of a short video providing an update on the facility at Harley Street and progress made on site. The video features Deconstruct (UK) Limited, principal contractor to the project, and highlights its role in the demolition, excavation and rebuild at […]

Bilby – Largest Gas Contractor in South East, Doubles Revenue

Bilby plc BILB With revenue doubling in the year to 31st March and gross profit rising from £6m. to £11.02m.,  Bilby has established itself as the largest gas contractor in London and the South East. However after various non underlying items, profit before tax fell from a restated £0.72m in 2016 to this years £0.06m.  […]

Advanced Oncotherapy (AVO) – Final results

Advanced Oncotherapy (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces audited results for the year ended 31 December 2016, another year of significant development of the Company’s LIGHT system. Highlights: ·     First successful acceleration of the proton beam through the proton source and Radio Frequency Quadrupole (RFQ) ·     Successful […]

Advanced Oncotherapy (AVO) – Conversion of Convertible Loan Notes

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group has advised the Company that they will convert a portion of the Convertible Loan Notes into new ordinary shares of 25p each in the share capital of the Company.  Further details of the conversion are set […]

DirectorsTalk – Q&A with Professor Steve Myers at Advanced Oncotherapy (AVO).

Advanced Oncotherapy PLC (LON:AVO) subsidiary ADAM S.A. Executive Chairman professor Steve Myers talks to DirectorsTalk about the LIGHT system, it’s likely impact, the design, the progress being made and its future. Q1: Professor Myers, you became Executive Chairman of ADAM S.A. (ADAM), the CERN spin-off and Advanced Oncotherapy’s (AVO’s) subsidiary, in late 2015, and joined AVO’s […]